Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Disparities in Plasma Cell Neoplasms in Kentucky, Appalachia and Other States: A Population Based Study

Ayman Qasrawi, MD, Richard L O'Neal, MD, Maxwell M. Krem, MD PhD, Gregory Monohan, MD, Reinhold Munker, MD, Gerhard C. Hildebrandt, MD

Blood (2019) 134 (Supplement_1): 4735.

https://doi.org/10.1182/blood-2019-127687

Published: 2019

Journal Articles

Socioeconomic Disparities Affect Survival of Classical Hodgkin Lymphoma in a Statewide Cancer Registry Analysis

Zin W. Myint, MD, Runa Shrestha, MBBS, Quan Chen, Bin Huang, Amit Goldberg, MD, Reshma Ramlal, MD, Gregory Monohan, MD, Roger A. Fleischman, MD PhD, Roger H. Herzig, MD, Gerhard Carl Hildebrandt, MD, Hayder Saeed, MD

Blood (2018) 132 (Supplement 1): 4836.

https://doi.org/10.1182/blood-2018-99-110988

Published: 2018

Journal Articles

Phase 2 Study of Venetoclax Plus Carfilzomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Luciano J Costa, MD PhD, Edward A. Stadtmauer, MD FACP, Gareth Morgan, MD, Gregory Monohan, MD, Tibor Kovacsovics, MD, Nicholas Burwick, MD, Andrzej Jakubowiak, MD PhD, Jonathan L Kaufman, MD, Mehrdad Mobasher, MD MPH, Kevin J. Freise, PhD, Jeremy A. Ross, PhD, John Pesko, PhD, Wijith Munasinghe, PhD, Saketh Gudipati, MD, Sarah Mudd, PhD, Orlando Bueno, MD PhD, Shaji K. Kumar, MD

Blood (2018) 132 (Supplement 1): 303.

https://doi.org/10.1182/blood-2018-99-117026

Published: 2018

Journal Articles

Consolidative Radiation with Chemotherapy in Early Stage Classical Hodgkin Lymphoma with Unfavorable Risk: The Kentucky Experience

Zin W Myint, MD, Runa Shrestha, MD, Jaclyn Nee, Bin Huang, Eric Durbin, Stacey Slone, Amit Goldberg, Maryam Zia, Reshma Ramlal, MD, Gregory Monohan, MD, Roger H. Herzig, MD, Roger A. Fleischman, MDPhD, Gerhard Carl Hildebrandt, MD, Hayder Saeed, MD

Blood (2017) 130 (Supplement 1): 5184.

https://doi.org/10.1182/blood.V130.Suppl_1.5184.5184

Published: 2017

Journal Articles

Changes in Killer-Cell Immunoglobulin-like Receptor (KIR) Expression on NK Cells Following DNA Demethylation By Azacitidine in Relapsed and Refractory Lymphomas

Runa Shrestha, MD, Ahmad Al-Attar, MD, John W Hayslip, MD, Lutz T Charles, MD, Emily Dressler, PhD, Jabbour Hossam, MD, Maryam F Zia, MD, Hayder Saeed, MD, Amit Goldberg, MD, Gregory Monohan, MD, Roger Herzig, MD, Roger A Fleischman, MD, PhD, Gerhard Hildebrandt, MD, Shams A Shakil, MD, PhD

Blood (2016) 128 (22): 5296.

https://doi.org/10.1182/blood.V128.22.5296.5296

Published: 2016

Journal Articles

Hyperferritinimia in Adults in the Critical Care Setting and Its Significance to Hemophagocytic Lymphohistiocytosis

Hayder Saeed, MD, Ryan Woods, MD, Joshua Lester, Gregory Monohan, MD

Blood (2014) 124 (21): 1412.

https://doi.org/10.1182/blood.V124.21.1412.1412

Published: 2014

Journal Articles

Is Rituximab Needed With High Dose Chemotherapy and Autologous Stem Cell Transplant When Patients With Non-Hodgkin’s Lymphoma Have Been Exposed To It?

Zartash Gul, MD, Stephan Anderson, MD, Stacey Slone, Saurabh Chhabra, MD, Gregory Monohan, MD, Dianna Howard, MD, Amber Lawson, PharmD, John Hayslip, MD

Blood (2013) 122 (21): 5552.

https://doi.org/10.1182/blood.V122.21.5552.5552

Published: 2013

NARROW

Disparities in Plasma Cell Neoplasms in Kentucky, Appalachia and Other States: A Population Based Study

Socioeconomic Disparities Affect Survival of Classical Hodgkin Lymphoma in a Statewide Cancer Registry Analysis

Phase 2 Study of Venetoclax Plus Carfilzomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Consolidative Radiation with Chemotherapy in Early Stage Classical Hodgkin Lymphoma with Unfavorable Risk: The Kentucky Experience

Changes in Killer-Cell Immunoglobulin-like Receptor (KIR) Expression on NK Cells Following DNA Demethylation By Azacitidine in Relapsed and Refractory Lymphomas

Hyperferritinimia in Adults in the Critical Care Setting and Its Significance to Hemophagocytic Lymphohistiocytosis

Is Rituximab Needed With High Dose Chemotherapy and Autologous Stem Cell Transplant When Patients With Non-Hodgkin’s Lymphoma Have Been Exposed To It?

Email alerts

ASH Publications

American Society of Hematology

Disparities in Plasma Cell Neoplasms in Kentucky, Appalachia and Other States: A Population Based Study

Socioeconomic Disparities Affect Survival of Classical Hodgkin Lymphoma in a Statewide Cancer Registry Analysis

Phase 2 Study of Venetoclax Plus Carfilzomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma

Consolidative Radiation with Chemotherapy in Early Stage Classical Hodgkin Lymphoma with Unfavorable Risk: The Kentucky Experience

Changes in Killer-Cell Immunoglobulin-like Receptor (KIR) Expression on NK Cells Following DNA Demethylation By Azacitidine in Relapsed and Refractory Lymphomas

Hyperferritinimia in Adults in the Critical Care Setting and Its Significance to Hemophagocytic Lymphohistiocytosis

Is Rituximab Needed With High Dose Chemotherapy and Autologous Stem Cell Transplant When Patients With Non-Hodgkin’s Lymphoma Have Been Exposed To It?

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only